ID   U-DCS
AC   CVCL_A2XZ
DR   Wikidata; Q105511292
RX   PubMed=33277516;
CC   Population: Caucasian.
CC   Doubling time: ~2 days (PubMed=33277516).
CC   HLA typing: A*11:01,24:02; B*15:01,35:01; C*03:03,04:01; DQB1*05:01,06:04; DRB1*01:01,13:02 (PubMed=33277516).
CC   Karyotypic information: More than tetraploid karyotype with approximately 130 chromosomes and multiple aberrations (PubMed=33277516).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=33277516
ST   Amelogenin: X,Y
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D8S1179: 13,15
ST   FGA: 22
ST   SE33: 19,26.2
ST   TH01: 6,9
ST   vWA: 14,15
DI   NCIt; C9282; Interdigitating dendritic cell sarcoma
DI   ORDO; Orphanet_86900; Interdigitating dendritic cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2YA ! LCL-U-DCS
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33277516; DOI=10.1038/s41598-020-77471-7; PMCID=PMC7718904;
RA   Mellert K., Benckendorff J., Leithauser F., Zimmermann K., Wiegand P.,
RA   Frascaroli G., Buck M., Malaise M., Hartmann G., Barchet W., Furst D.,
RA   Mytilineos J., Mayer-Steinacker R., Viardot A., Moller P.;
RT   "U-DCS: characterization of the first permanent human dendritic
RT   sarcoma cell line.";
RL   Sci. Rep. 10:21221.1-21221.11(2020).
//